Hobin Yang
Impact in
-
- Cancer Genomics and Diagnostics
-
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 10
- Cancer Cells and Metastasis 3
- CAR-T cell therapy research 2
- PARP inhibition in cancer therapy 2
-
- Protein Degradation and Inhibitors 2
- Co-authors
- Young Kee Shin (10 shared papers)Naixin Liang (1 shared paper)Hui Ren (1 shared paper)Jianbin Xu (1 shared paper)Sheng Li (1 shared paper)Cheng Huang (1 shared paper)Jae‐Heon Kang (1 shared paper)Lifen Ren‐Heidenreich (1 shared paper)
- Journals
- Pharmaceuticals (2 papers)Cancer Research and Treatment (2 papers)Cancer Research (2 papers)British Journal of Cancer (1 paper)Translational Oncology (1 paper)
- Partner nations
- South KoreaEthiopiaChina
In The Last Decade
Hobin Yang
12 papers receiving 354 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 125
- Oncology 188
- Pulmonary and Respiratory Medicine 185
- Molecular Biology 162
- Immunology 37
Countries citing papers authored by Hobin Yang
This map shows the geographic impact of Hobin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hobin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hobin Yang more than expected).
Fields of papers citing papers by Hobin Yang
This network shows the impact of papers produced by Hobin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hobin Yang. The network helps show where Hobin Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hobin Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 179 | |
| 2 | 2022 | 53 | |
| 3 | 2021 | 46 | |
| 4 | 2020 | 27 | |
| 5 | 2022 | 12 | |
| 6 | 2009 | 12 | |
| 7 | 2019 | 9 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 6 | |
| 10 | 2022 | 3 | |
| 11 | 2024 | 2 | |
| 12 | 2022 | 2 | |
| 13 | 2025 | 0 | |
| 14 | 2025 | 0 |
About Hobin Yang
Hobin Yang is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 357 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Cells and Metastasis (3 papers), Protein Degradation and Inhibitors (2 papers), CAR-T cell therapy research (2 papers), PARP inhibition in cancer therapy (2 papers), Caveolin-1 and cellular processes (2 papers), Barrier Structure and Function Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Cancer Research (125 citations), Oncology (188 citations), Pulmonary and Respiratory Medicine (185 citations), Molecular Biology (162 citations) and Immunology (37 citations). Hobin Yang has collaborated with scholars based in South Korea, Ethiopia and China. Frequent co-authors include Young Kee Shin, Naixin Liang, Hui Ren, Jianbin Xu, Sheng Li, Cheng Huang, Jae‐Heon Kang, Lifen Ren‐Heidenreich, Wei Wang and Yifang Zhu. Their work appears in journals such as Pharmaceuticals, Cancer Research and Treatment, Cancer Research, British Journal of Cancer and Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.